Use of medications and risk of revision after primary total hip arthroplasty

Reference list

• Almog Y. Statins, inflammation, and sepsis: hypothesis. Chest 2003; 124(2):740-743.
   Google Scholar
• Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110(7):880-885.
   Google Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46(3):263-268.
   Google Scholar
• Arabmotlagh M, Rittmeister M, Hennigs T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res 2006; 24(7):1336-1341.
   Google Scholar
• Aubin R, Menard P, Lajeunesse D. Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int 1996; 50(5):1476-1482.
   Google Scholar
• Ayukawa Y, Okamura A, Koyano K. Simvastatin promotes osteogenesis around titanium implants. Clin Oral Implants Res 2004; 15(3):346-350.
   Google Scholar
• Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol 1997; 272(1 Pt 1):C109-C116.
   Google Scholar
• Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non-lipid-related effects of statins. Ann Med 2000; 32(3):164-176.
   Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312(7040): 1215-1218.
   PubMed Web of Science ®Google Scholar
• Bobyn JD, Hacking SA, Krygier JJ, Harvey EJ, Little DG, Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br 2005; 87(3):416-420.
   Google Scholar
• Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 2007; 18(4):479-486.
   Google Scholar
• Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A, LaCroix AZ. Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative. Arch Intern Med 2009; 169(2):132-140.
   Google Scholar
• Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000; 355(9222):2185-2188.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373-383.
   PubMedGoogle Scholar
• Charnley J. Arthroplasty of the hip. A new operation. Lancet 1961; 1(7187):1129-1132.
   Google Scholar
• Charnley J. The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg Br 1972; 54(1):61-76.
   PubMedGoogle Scholar
• Charnley J, Cupic Z. The nine and ten year results of the low-friction arthroplasty of the hip. Clin Orthop Relat Res 1973;(95): 9-25.
   Google Scholar
• Collet JP, Boivin JF. Pharmacoepidemiology. John Wiley & sons, Ltd., 2000.
   Google Scholar
• Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009; 119(15):2051-2057.
   PubMed Web of Science ®Google Scholar
• Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83(9):1032-1045.
   Google Scholar
• Eberhardt C, Stumpf U, Brankamp J, Schwarz M, Kurth AH. Osseointegration of cementless implants with different bisphosphonate regimens. Clin Orthop Relat Res 2006; 447:195-200.
   PubMed Web of Science ®Google Scholar
• Espehaug B, Havelin LI, Engesaeter LB, Langeland N, Vollset SE. Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 1997; 68(3):207-215.
   Google Scholar
• Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev 2006;(1): CD003838.
   Google Scholar
• Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA 1991; 265(3):370-373.
   Google Scholar
• Fletcher RW, Fletcher SW. Clinical epidemiology: The essentials. Lippincott Williams and Wilkins, Baltimore, 2005.
   Google Scholar
• Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Meyer HE. Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in 50,034 persons. Arthritis Rheum 2002; 46(3):675-682.
   Google Scholar
• Fokter SK, Komadina R, Repse-Fokter A, Yerby SA, Kocijancic A, Marc J. Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty. Int Orthop 2005; 29(6):362-367.
   Google Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287(5462):2398-2399.
   Google Scholar
• Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. J Bone Joint Surg Br 2001; 83(4):579-586.
   PubMedGoogle Scholar
• Garellick G, Malchau H, Herberts P, Hansson E, Axelsson H, Hansson T. Life expectancy and cost utility after total hip replacement. Clin Orthop Relat Res 1998;(346): 141-151.
   Google Scholar
• Garrett IR, Gutierrez GE, Rossini G, Nyman J, McCluskey B, Flores A, Mundy GR. Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J Orthop Res 2007; 25(10):1351-1357.
   Google Scholar
• Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol 2006; 59(8):819-828.
   Google Scholar
• Gromov K, Huang W, Li D, Ulrich-Vinter M, Lu A, Søballe K, O'Keefe RJ, Schwartz E. Osteoclastic bone resorption in chronic osteomyelitis. The Danish Orthopaedic Society's Annual Meeting 2008. 2008.
   Google Scholar
• Ref Type: Personal Communication.
   Google Scholar
• Gutierrez GE, Lalka D, Garrett IR, Rossini G, Mundy GR. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int 2006.
   Google Scholar
• Hall TJ, Schaueblin M. Hydrochlorothiazide inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int 1994; 55(4):266-268.
   Google Scholar
• Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 1969; 51(4):737-755.
   PubMed Web of Science ®Google Scholar
• Havelin LI, Fenstad AM, Salomonsson R, Mehnert F, Furnes O, Overgaard S, Pedersen AB, Herberts P, Karrholm J, Garellick G. The Nordic Arthroplasty Register Association. Acta Orthop 2009; 1-9.
   Google Scholar
• Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med 1991; 115(1):1-6.
   Google Scholar
• Herberts P, Malchau H. How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop Relat Res 1997;(344): 44-60.
   Google Scholar
• Herberts P, Malchau H. Long-term registration has improved the quality of hip replacement: a review of the Swedish THR Register comparing 160,000 cases. Acta Orthop Scand 2000; 71(2):111-121.
   PubMedGoogle Scholar
• Herings RM, Stricker BH, de BA, Bakker A, Sturmans F, Stergachis A. Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol 1996; 49(1):115-119.
   Google Scholar
• Hilding M, Aspenberg P. Postoperative clodronate decreases prosthetic migration: 4-year follow-up of a randomized radiostereometric study of 50 total knee patients. Acta Orthop 2006; 77(6):912-916.
   PubMed Web of Science ®Google Scholar
• Hilding M, Aspenberg P. Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients. Acta Orthop 2007; 78(6):795-799.
   PubMed Web of Science ®Google Scholar
• Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71(6):553-557.
   PubMedGoogle Scholar
• Johnsen SP, Sorensen HT, Lucht U, Soballe K, Overgaard S, Pedersen AB. Patient-related predictors of implant failure after primary total hip replacement in the initial, short- and long-terms: A nationwide follow-up study including 36,984 patients. J Bone Joint Surg Br 2006; 88(10):1303-1308.
   PubMedGoogle Scholar
• Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 1995; 10(1):106-111.
   Google Scholar
• Karrholm J, Borssen B, Lowenhielm G, Snorrason F. Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. J Bone Joint Surg Br 1994; 76(6):912-917.
   PubMedGoogle Scholar
• LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133(7):516-526.
   Google Scholar
• Laing AJ, Dillon JP, Mulhall KJ, Wang JH, McGuinness AJ, Redmond PH. Statins attenuate polymethylmethacrylate-mediated monocyte activation. Acta Orthop 2008; 79(1):134-140.
   Google Scholar
• LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282(24):2340-2346.
   Google Scholar
• Larsen J, Andersen M, Kragstrup J, Gram LF. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol 2002; 53(4):375-378.
   Google Scholar
• Lemann J, Jr., Gray RW, Maierhofer WJ, Cheung HS. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 1985; 28(6):951-958.
   Google Scholar
• Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Jr., Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995; 333(22):1437-1443.
   PubMed Web of Science ®Google Scholar
• Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE. Loop Diuretic Use and Increased Rates of Hip Bone Loss in Older Men: The Osteoporotic Fractures in Men Study. Arch Intern Med 2008; 168(7):735-740.
   Google Scholar
• Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop Scand 2000; 71(5):433-439.
   PubMedGoogle Scholar
• Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357(18):1799-1809.
   PubMed Web of Science ®Google Scholar
• Lyons AR, Owen JE, Freeholm DA, Effect of alendronate on periprosthetic bone mass. Transactions of the 10th Combined Meeting of the Orthopaedic Association of the English Speeking World, Auckland, New Zealand, February 1-6, 1998, p 209. 2009.
   Google Scholar
• Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001; 280(3):874-877.
   Google Scholar
• Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand 1993; 64(5):497-506.
   Google Scholar
• Malchau H, Herberts P, Eisler T, Garellick G, Soderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002; 84-A Suppl 2: 2-20.
   PubMed Web of Science ®Google Scholar
• Maloney WJ. National Joint Replacement Registries: has the time come? J Bone Joint Surg Am 2001; 83-A(10):1582-1585.
   Google Scholar
• Marcelo Coca-Perraillon. SAS Global Forum 185-2007, Harvard Medical School, Boston. 2007.
   Google Scholar
• Maritz FJ, Conradie MM, Hulley PA, Gopal R, Hough S. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 2001; 21(10):1636-1641.
   Google Scholar
• McMahon AD. Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf 2003; 12(7):551-558.
   Google Scholar
• Meghji S, Crean SJ, Hill PA, Sheikh M, Nair SP, Heron K, Henderson B, Mawer EB, Harris M. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Br J Rheumatol 1998; 37(10):1095-1101.
   Google Scholar
• Merx H, Dreinhofer K, Schrader P, Sturmer T, Puhl W, Gunther KP, Brenner H. International variation in hip replacement rates. Ann Rheum Dis 2003; 62(3):222-226.
   Google Scholar
• Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129(1):125-137.
   Google Scholar
• Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002; 84-A(2):236-249.
   Google Scholar
• Moriyama Y, Ayukawa Y, Ogino Y, Atsuta I, Koyano K. Topical application of statin affects bone healing around implants. Clin Oral Implants Res 2008; 19(6):600-605.
   Google Scholar
• Morris RW. A statistical study of papers in the Journal of Bone and Joint Surgery [BR] 1984. J Bone Joint Surg Br 1988; 70(2):242-246.
   Google Scholar
• Mortensen EM, Pugh MJ, Copeland LA, Restrepo MI, Cornell JE, Anzueto A, Pugh JA. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. Eur Respir J 2008; 31(3):611-617.
   Google Scholar
• Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005; 6:82.
   PubMed Web of Science ®Google Scholar
• Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286(5446):1946-1949.
   Google Scholar
• Murray DW, Carr AJ, Bulstrode CJ. Which primary total hip replacement? J Bone Joint Surg Br 1995; 77(4):520-527.
   Google Scholar
• Nercessian OA, Joshi RP, Martin G, Su BW, Eftekhar NS. Influence of demographic and technical variables on the incidence of osteolysis in Charnley primary low-friction hip arthroplasty. J Arthroplasty 2003; 18(5):631-637.
   Google Scholar
• Older J. Charnley low-friction arthroplasty: a worldwide retrospective review at 15 to 20 years. J Arthroplasty 2002; 17(6):675-680.
   Google Scholar
• Ooms ME, Lips P, Van LA, Valkenburg HA. Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 1993; 8(6):669-675.
   Google Scholar
• Oxlund H, Dalstra M, Andreassen TT. Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcif Tissue Int 2001; 69(5):299-304.
   Google Scholar
• Partanen J, Heikkinen J, Jamsa T, Jalovaara P. Characteristics of lifetime factors, bone metabolism, and bone mineral density in patients with hip fracture. J Bone Miner Metab 2002; 20(6):367-375.
   Google Scholar
• Pedersen A, Johnsen S, Overgaard S, Soballe K, Sorensen HT, Lucht U. Registration in the danish hip arthroplasty registry: completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop Scand 2004; 75(4):434-441.
   PubMedGoogle Scholar
• Pedersen AB, Johnsen SP, Overgaard S, Soballe K, Sorensen HT, Lucht U. Total hip arthroplasty in Denmark: incidence of primary operations and revisions during 1996-2002 and estimated future demands. Acta Orthop 2005; 76(2):182-189.
   PubMedGoogle Scholar
• Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 2005; 36(1):52-60.
   PubMed Web of Science ®Google Scholar
• Phillips S, Fox N, Jacobs J, Wright WE. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988; 9(5):271-279.
   Google Scholar
• Ray NF, Chan JK, Thamer M, Melton LJ, III. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12(1):24-35.
   PubMed Web of Science ®Google Scholar
• Ray WA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev 2002; 8(4):276-279.
   Google Scholar
• Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109(5):362-370.
   Google Scholar
• Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet 2001; 357(9255):509-512.
   Google Scholar
• Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sorensen HT, Mosekilde L. Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int 2004; 15(6):452-458.
   Google Scholar
• Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med 2005a; 257(2):176-184.
   Google Scholar
• Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 2006a; 21(1):163-170.
   Google Scholar
• Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 2005b; 76(3):167-175.
   Google Scholar
• Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Intern Med 2006b; 259(1):117-124.
   Google Scholar
• Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int 2006c; 79(1):27-36.
   Google Scholar
• Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 2003; 33(1):41-50.
   PubMed Web of Science ®Google Scholar
• Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. J Clin Invest 1996; 97(12):2692-2696.
   Google Scholar
• Rose BD. Diuretics. Kidney Int 1991; 39(2):336-352.
   Google Scholar
• Rothman KJ. Epidemiology, an introduction. Oxford University Press, New York 2002.
   Google Scholar
• Ryd L, Albrektsson BE, Carlsson L, Dansgard F, Herberts P, Lindstrand A, Regner L, Toksvig-Larsen S. Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg Br 1995; 77(3):377-383.
   PubMedGoogle Scholar
• Schoofs MW, Sturkenboom MC, van der KM, Hofman A, Pols HA, Stricker BH. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 2004; 19(9):1525-1530.
   Google Scholar
• Schoofs MW, van der KM, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139(6):476-482.
   Google Scholar
• Shanbhag AS. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 2006; 14(4):215-225.
   Google Scholar
• Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997;(344): 33-43.
   Google Scholar
• Sigurdsson G, Franzson L. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Intern Med 2001; 250(1):51-56.
   Google Scholar
• Skoglund B, Aspenberg P. Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord 2007; 8:98.
   PubMed Web of Science ®Google Scholar
• Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002; 17(11):2004-2008.
   Google Scholar
• Soballe K, Chen X, Jensen TB, Kidder L, Bechtold JE. Alendronate treatment in the revision setting, with and without controlled implant motion: an experimental study in dogs. Acta Orthop 2007; 78(6):800-807.
   Google Scholar
• Somayaji SN, Ritchie S, Sahraei M, Marriott I, Hudson MC. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun 2008; 76(11):5120-5126.
   Google Scholar
• Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution. Clin Orthop Relat Res 2005; 441:30-39.
   PubMed Web of Science ®Google Scholar
• Thillemann TM, Pedersen AB, Johnsen SP, Soballe K. Implant survival after primary total hip arthroplasty due to childhood hip disorders: results from the Danish Hip Arthroplasty Registry. Acta Orthop 2008; 79(6):769-776.
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 2008; 168(19):2081-2087.
   Google Scholar
• Toh S, Hernandez-Diaz S. Statins and fracture risk. A systematic review. Pharmacoepidemiol Drug Saf 2007; 16(6):627-640.
   Google Scholar
• Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD. Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 2000; 85(9):3109-3115.
   Google Scholar
• Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P. Predictors of fractures in elderly women. Osteoporos Int 2000; 11(2):134-140.
   Google Scholar
• Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362(9395):1527-1535.
   PubMed Web of Science ®Google Scholar
• Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 2007; 40(6):1581-1587.
   Google Scholar
• van Beek ER, Cohen LH, Leroy IM, Ebetino FH, Lowik CW, Papapoulos SE. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone 2003; 33(5):805-811.
   PubMedGoogle Scholar
• van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C. Use of statins and risk of fractures. JAMA 2001; 285(14):1850-1855.
   Google Scholar
• Venesmaa PK, Kroger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhav EM. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res 2001; 16(11):2126-2131.
   Google Scholar
• von Knoch F, Wedemeyer C, Heckelei A, Saxler G, Hilken G, Brankamp J, Sterner T, Landgraeber S, Henschke F, Loer F, von Knoch M. Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis. Biomaterials 2005a; 26(29):5783-5789.
   Google Scholar
• von Knoch M, Wedemeyer C, Pingsmann A, von Knoch F, Hilken G, Sprecher C, Henschke F, Barden B, Loer F. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 2005b; 26(14):1803-1808.
   Google Scholar
• Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992; 135(9):1042-1050.
   Google Scholar
• Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 2007; 18(12):1641-1650.
   Google Scholar
• Wedemeyer C, von Knoch F, Pingsmann A, Hilken G, Sprecher C, Saxler G, Henschke F, Loer F, von Knoch M. Stimulation of bone formation by zoledronic acid in particle-induced osteolysis. Biomaterials 2005; 26(17):3719-3725.
   Google Scholar
• Wells VM, Hearn TC, McCaul KA, Anderton SM, Wigg AE, Graves SE. Changing incidence of primary total hip arthroplasty and total knee arthroplasty for primary osteoarthritis. J Arthroplasty 2002; 17(3):267-273.
   PubMedGoogle Scholar
• Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, Heiss G, Lalouel JM, Turner ST, Hunt SC, Province MA, Rao DC. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 2005; 18(7):935-942.
   Google Scholar
• Yamaguchi K, Masuhara K, Yamasaki S, Nakai T, Fuji T. Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty. Bone 2003; 33(1):144-149.
   Google Scholar
• Yamasaki S, Masuhara K, Yamaguchi K, Nakai T, Fuji T, Seino Y. Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty. Osteoporos Int 2007; 18(7):1009-1015.
   Google Scholar